Medications

1st drug for tardive dyskinesia approved

(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.

Immunology

Rescue protein gives doomed cells a stay of 'execution'

A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis. The ...

Medical research

Identification of autophagy-dependent secretion machinery

A group of researchers identified a molecular machinery by which autophagy mediates secretion. These results underscore an important role of autophagy other than degradation, and will bring us to future translational research ...

Medical research

New construction role found for cell demolition tool

A new role has been discovered for a well-known piece of cellular machinery, which could revolutionise the way we understand how tissue is constructed and remodelled within the body.

Oncology & Cancer

Change in a single DNA base drives a childhood cancer

Pediatric oncology researchers have pinpointed a crucial change in a single DNA base that both predisposes children to an aggressive form of the childhood cancer neuroblastoma and makes the disease progress once tumors form.

page 2 from 8